Interestingly, WIP1 function can be regulated by phosphoglycerate mutase 1 (PGAM1), a glycolytic enzyme that is overexpressed in cancer tissues and that is able to block WIP1 cytoprotective function upon chemo- and radiotherapy in glioma (Ohba et al., 2020). This evidence concerns the gene PPM1D and cancer.